NFASC and myeloid sarcoma: The authors suggested that the antibodies may facilitate the adsorption of the SLNs to myelin due to binding to the related antigens, i.e., Contactin2 or Neurofascin, on the CNS axon, and the above information would help toward the development of more efficient nanocarriers for the treatment of MS.